About: Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • The effect of replacement of the N,N-chelating ligand 1,10-phenanthroline (phen) in the Ir-III pentamethylcyclopentadienyl (Cp-star) complex [(eta(5)-Cp-star)(Ir)(phen) Cl](+) (2) with the C,N-chelating ligand 7,8-benzoquinoline (bq) to give [(eta(5)-Cp-star)(Ir)(bq)Cl] (1) on the cytotoxicity of these (CpIrIII)-Ir-star complexes toward cancer cell lines was investigated. Complex 2 is inactive, similar to other (CpIrIII)-Ir-star complexes containing the N, N-chelating ligands. In contrast, a single atom change (C- for N) in the chelating N, N ligand resulted in potency in human ovarian carcinoma cisplatin-sensitive A2780 cells, and, strikingly, 1 is active in the cisplatin-resistant human breast cancer MCF-7 and A2780/cisR cells. Replacement of the N,N-chelating ligand with the C,N-chelating ligand gives rise to increased hydrophobicity, leading to higher cellular accumulation, higher DNA-bound iridium in cells and higher cytotoxicity. The pathways involved in cellular accumulation of 1 have been further explored and compared with conventional cisplatin. The results show that both energy-independent passive diffusion and energy-dependent transport play a role in accumulation of 1.
  • The effect of replacement of the N,N-chelating ligand 1,10-phenanthroline (phen) in the Ir-III pentamethylcyclopentadienyl (Cp-star) complex [(eta(5)-Cp-star)(Ir)(phen) Cl](+) (2) with the C,N-chelating ligand 7,8-benzoquinoline (bq) to give [(eta(5)-Cp-star)(Ir)(bq)Cl] (1) on the cytotoxicity of these (CpIrIII)-Ir-star complexes toward cancer cell lines was investigated. Complex 2 is inactive, similar to other (CpIrIII)-Ir-star complexes containing the N, N-chelating ligands. In contrast, a single atom change (C- for N) in the chelating N, N ligand resulted in potency in human ovarian carcinoma cisplatin-sensitive A2780 cells, and, strikingly, 1 is active in the cisplatin-resistant human breast cancer MCF-7 and A2780/cisR cells. Replacement of the N,N-chelating ligand with the C,N-chelating ligand gives rise to increased hydrophobicity, leading to higher cellular accumulation, higher DNA-bound iridium in cells and higher cytotoxicity. The pathways involved in cellular accumulation of 1 have been further explored and compared with conventional cisplatin. The results show that both energy-independent passive diffusion and energy-dependent transport play a role in accumulation of 1. (en)
Title
  • Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand
  • Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand (en)
skos:prefLabel
  • Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand
  • Mechanism of cellular accumulation of an iridium(III) pentamethylcyclopentadienyl anticancer complex containing a C,N-chelating ligand (en)
skos:notation
  • RIV/68081707:_____/14:00428115!RIV15-AV0-68081707
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, P(EE2.3.20.0057), S
http://linked.open...iv/cisloPeriodika
  • 3
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 28125
http://linked.open...ai/riv/idVysledku
  • RIV/68081707:_____/14:00428115
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • HUMAN OVARIAN-CANCER; DRUG-RESISTANCE; P-GLYCOPROTEIN (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [289F1CE37EEF]
http://linked.open...i/riv/nazevZdroje
  • Metallomics
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 6
http://linked.open...iv/tvurceVysledku
  • Brabec, Viktor
  • Kašpárková, Jana
  • Sadler, P. J.
  • Vojtíšková, Marie
  • Novohradský, Vojtěch
  • Liu, Z.
http://linked.open...ain/vavai/riv/wos
  • 000333565800030
issn
  • 1756-5901
number of pages
http://bibframe.org/vocab/doi
  • 10.1039/c3mt00341h
Faceted Search & Find service v1.16.116 as of Feb 22 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3239 as of Feb 22 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 82 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software